Alan P Baptist1, Wei Hao2, Peter X Song2, Laurie Carpenter3, Joel Steinberg4, Lavoisier J Cardozo4. 1. Division of Allergy and Clinical Immunology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan; University of Michigan School of Public Health, Ann Arbor, Michigan. Electronic address: abaptist@med.umich.edu. 2. University of Michigan School of Public Health, Ann Arbor, Michigan. 3. Division of Allergy and Clinical Immunology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan. 4. Division of Geriatric Medicine, Department of Internal Medicine, Wayne State University, Detroit, Michigan.
Abstract
BACKGROUND:Older adults have higher rates of asthma morbidity and mortality compared with younger age groups. Few interventions are tailored to this population. OBJECTIVE: To evaluate a self-management asthma intervention in older adults. METHODS:Adults age 55 and older with persistent asthma were enrolled into blinded, randomized controlled trial of a 6-session asthma self-management intervention. This educational intervention was conducted in group sessions and through individual telephone calls. Outcomes including asthma exacerbations (defined as unscheduled office visits, emergency department visits, or hospitalizations for asthma), spirometric values, FeNO, asthma control, asthma quality of life, and asthma self-management were assessed at 3, 6, and 12 months. RESULTS:One hundred eighty-nine subjects were enrolled, 172 were randomized and received at least 1 treatment dose, and 145 (84%) were analyzed at 12 months. On a modified intent-to-treat analysis, those in the intervention group were less likely to have an asthma exacerbation (26.9% vs 47.1%, P = .01), had a lower asthma exacerbation rate (0.8 vs 1.9, P = .02), had better asthma control (19.9 vs 18.6, P = .08), and had a higher asthma self-management score (8.9 vs 8.4, P = .03). After a mixed-model analysis to control for confounding factors, a decrease in asthma exacerbations (P = .02), as well as a decreased asthma exacerbation rate (P = .04), remained statistically significant, whereas asthma control and self-management did not. No other significant outcome differences were found. CONCLUSION: A 6-session asthma self-management intervention can successfully decrease asthma exacerbations among older adults.
RCT Entities:
BACKGROUND: Older adults have higher rates of asthma morbidity and mortality compared with younger age groups. Few interventions are tailored to this population. OBJECTIVE: To evaluate a self-management asthma intervention in older adults. METHODS: Adults age 55 and older with persistent asthma were enrolled into blinded, randomized controlled trial of a 6-session asthma self-management intervention. This educational intervention was conducted in group sessions and through individual telephone calls. Outcomes including asthma exacerbations (defined as unscheduled office visits, emergency department visits, or hospitalizations for asthma), spirometric values, FeNO, asthma control, asthma quality of life, and asthma self-management were assessed at 3, 6, and 12 months. RESULTS: One hundred eighty-nine subjects were enrolled, 172 were randomized and received at least 1 treatment dose, and 145 (84%) were analyzed at 12 months. On a modified intent-to-treat analysis, those in the intervention group were less likely to have an asthma exacerbation (26.9% vs 47.1%, P = .01), had a lower asthma exacerbation rate (0.8 vs 1.9, P = .02), had better asthma control (19.9 vs 18.6, P = .08), and had a higher asthma self-management score (8.9 vs 8.4, P = .03). After a mixed-model analysis to control for confounding factors, a decrease in asthma exacerbations (P = .02), as well as a decreased asthma exacerbation rate (P = .04), remained statistically significant, whereas asthma control and self-management did not. No other significant outcome differences were found. CONCLUSION: A 6-session asthma self-management intervention can successfully decrease asthma exacerbations among older adults.
Authors: Chih-Hung Chang; Lisa K Sharp; Linda G Kimmel; Leslie C Grammer; Romina Kee; John J Shannon Journal: Ann Allergy Asthma Immunol Date: 2007-08 Impact factor: 6.347
Authors: Michelle P Lin; Carmen Vargas-Torres; Jeremiah D Schuur; Dorothy Shi; Juan Wisnivesky; Lynne D Richardson Journal: J Asthma Date: 2019-06-12 Impact factor: 2.515
Authors: Elizabeth A Beverly; Shane Fitzgerald; Lilya Sitnikov; Om P Ganda; A Enrique Caballero; Katie Weinger Journal: Diabetes Care Date: 2013-01-11 Impact factor: 19.112
Authors: Kyma Schnoor; Anke Versluis; Robbert Bakema; Sanne van Luenen; Marcel J Kooij; J Maurik van den Heuvel; Martina Teichert; Persijn J Honkoop; Job F M van Boven; Niels H Chavannes; Jiska J Aardoom Journal: J Med Internet Res Date: 2022-06-08 Impact factor: 7.076